2BANCHEREAU J, STEIMAN R. Dendritic cell and the control of immunity[J]. Nature , 1998,392(19) :245-252.
3PAGLIA P,CCHIODONIO M,RODOLFO W, et al . Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo [J]. J Exp Med ,1996,183:317-322.
4MINEV B, HIPP J, FIRAT H, et al . Cytotoxic T cell immunity against telomerase reverse transcriptase in humen[J]. Proc Natl Acad Sci USA .2000,97(9) ,4796-4801.
5ATHANASSIADOU P,BANTIS A,GONIDI M, et al. Telomerase expression as a marker in prostate cancer:correlation to clinicopathologic predictors[J]. J Exp Clin Cancer Res ,2003,22(4):613-618.
6WEINRICH SL,PRUZAN R,MA L, et al . Reconstruction of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT[J]. Nat Genet , 1997, 17(4) :498-502.
7de GLINNOCENTI E,GRIONI M,BONI A, et al. Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization[J]. Eur J Immunol ,2005.35(1):66-75.
8FROLKIS M,FISCHER MB,WANG Z, et al . Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors [J].Cancer Gene Ther , 2003,10(3) :239-249.
9SIEVERS E,ALBERS P,SCHMIDT-WOLF IG, et al. Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma[J]. J Urol ,2004,171(1):114-119.
